Tech Company Financing Transactions

ViewPoint Therapeutics Funding Round

On 5/6/2016, ViewPoint Therapeutics announced $4 million in Series A investment from Lagunita Capital, Mission Bay Capital and Asset Management Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

290 Utah Ave. 300
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.viewpointtherapeutics.com

Email Address

[email protected]

Overview

ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Medical Officer

Robert Kim

        

Chief Scientific Officer

Leah Makley

        

Browse more venture capital transactions:

Prev: 5/6/2016: Humanyze venture capital transaction
Next: 5/6/2016: Eonite Perception venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary